Hydrogenated pyrido [4,3-b] indoles such as dimebon for treating canine Cognitive Dysfunction Syndrome

Details for Australian Patent Application No. 2007297618 (hide)

Owner Medivation Neurology, Inc.

Inventors Hung, David

Agent Davies Collison Cave

Pub. Number AU-A-2007297618

PCT Pub. Number WO2008/036400

Priority 60/846,152 20.09.06 US

Filing date 20 September 2007

Wipo publication date 27 March 2008

International Classifications

A61K 31/437 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

14 May 2009 PCT application entered the National Phase

  PCT publication WO2008/036400 Priority application(s): WO2008/036400

31 March 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007297622-Antenna for thoracic radio interrogation

2007297617-Common component framework